CDK4 and breast cancer: Previous studies combining low doses of CDK4/6i with RT demonstrate clinically meaningful radiosensitization in ER+ breast cancer models (17), though others have since suggested that combination treatment may be most effective when RT is administered prior to CDK4/6 inhibitor therapy (18).